UroGen Pharma General Counsel Jason Drew Smith exercised Options for 3,334 shares and later sold 1,519 shares at $42.54 each. His resulting holding was 53,141 shares after the sale, while the option exercise left him with no derivative securities. The transactions alter his direct Equity exposure.

Key Highlights

  • Smith Jason Drew held 54,660 shares after exercising options.
  • The option exercise represented 100.0% of his prior derivative securities holding.
  • The later sale represented about 2.8% of his prior shares holding.

UroGen Pharma Ltd. (NASDAQ: URGN) General Counsel Jason Drew Smith sold 1,519 shares at $42.54 per share on Sep. 8. His share ownership afterward stood at 53,141 shares.

Option Exercise and Resulting Holdings

Smith exercised options for 3,334 shares on Sep. 7, leaving him with 54,660 shares after the transaction. The exercise represented about 6.1% of his resulting shares holding. The same Sep. 7 transaction covered 3,334 derivative securities. Smith then owned zero derivative securities, representing about 100.0% of his prior derivative securities holding.